MedPath

Validation of non-radiative MRI-based multi-atlas attenuation correction for single-photon emission computed tomography

Conditions
G20.0
Registration Number
DRKS00032584
Lead Sponsor
niklinik Köln, Klinik für Nuklearmedizin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
12
Inclusion Criteria

1.Parkinson’s Disease (Hoehn and Yahr <3)
2.Participant of the DoMoCo study who previously gave consent that they can be contacted in the future for scientific purpose
3.DAT-SPECT at the Department of Nuclear Medicine for diagnostic purpose
4.Compatible MRI as part of DoMoCo study
5.Written informed consent

Exclusion Criteria

1.Any radiation exposure in the recent 10 years for scientific or therapy purposes
2.Pregnancy/breast feeding
3.Severe physical illness/physical conditions
4.Claustrophobia or excessive overweight

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The aim of the study:<br>Validation of an MRI-based attenuation correction for the evaluation of the 123I-FP-CIT signal in the brain by comparison with a CT-based attenuation correction.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath